Hikma Pharmaceuticals USA INC. recalls
2 recalls filed under Hikma Pharmaceuticals USA INC.. The most recent was published September 2, 2026.
-
Class II · last month
Hikma Pharmaceuticals USA INC. Ramipril Capsules USP, 10 mg recall: Failed Impurities/Degradation Specifications: OOS result obtained
Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
-
Class II · 6 months ago
Hikma Pharmaceuticals USA INC Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL recall: This recall is being conducted due to out of specification assay results
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
About this page
Hikma Pharmaceuticals USA INC. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.